How Did OpenEvidence Reach Two Thirds of Doctors?

Nworah Ayogu said OpenEvidence spread because doctors wanted it. Nworah Ayogu said he had never heard doctors rave about a clinical tool. Clinics normally force software on physicians, the way someone forces a pager or an enterprise tool, then monitors the work and flogs people for using it. The old thesis said doctors just do not like technology. He rejected the thesis: doctors have iPhones and Macs at home and simply hate the bad technology they are forced to use.

Friends from residency were the first to mention OpenEvidence, one of Nworah Ayogu's companies, and they did it with joy. He tried the product, called it differentiated, emailed a college friend behind it, drove to the house, and met that day. A clinician sees right away why OpenEvidence is an N of one product. Two thirds of physicians in America use OpenEvidence. Epic, called the behemoth in health care, took 40 years to reach today's scale and still has less than 50 percent of physicians using the product. OpenEvidence got to two thirds after three years.

He said the speed is the kind of scale now possible with a user population that is notoriously hard to gain adoption for.